MedDataX Logo

Group Music Therapy for Acquired Brain Injury

NCT ID: NCT06343662

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to analyse the impact of music therapy-based treatment on the comfort and well-being of patients with acquired brain injury (ABI). To achieve this objective, it is proposed to validate and implement a music therapy-based assessment and treatment protocol. The protocol will be tested in a pilot sample to improve adaptation to the disease and promote integration with the usual health measures of patients with ABI. Implementing a group treatment programme based on music therapy applied to patients with ABI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Brain Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

music therapy-based treatment psychological intervention discomfort Acquired Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Intervention: Control Group

Patients who receive the treatment program, will previously constitute their own control group (waiting list control group).

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental group

Patients admitted to the brain injury unit will participate in a music therapy protocol starting one week after admission. Prior to the group session, three evaluations will be conducted over six days. Post-treatment assessments will also be conducted to enable longitudinal evaluation of the patient over the course of a week.

Group Type EXPERIMENTAL

MERAKI_ABI

Intervention Type BEHAVIORAL

The music therapy session will focus on the themes of reidentification and involvement. The aim is to accompany the patient during the illness process, allowing them to express their emotional state, relate to music, promote listening and communication between family members, help and value preserved abilities, and promote personal involvement in the rehabilitation process.

The session will work with songs, taking into account musical preferences.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MERAKI_ABI

The music therapy session will focus on the themes of reidentification and involvement. The aim is to accompany the patient during the illness process, allowing them to express their emotional state, relate to music, promote listening and communication between family members, help and value preserved abilities, and promote personal involvement in the rehabilitation process.

The session will work with songs, taking into account musical preferences.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with acquired brain damage who has been admitted to the hospital for at least one week. The patient has experienced a sudden brain injury resulting in physical, psychological, cognitive, behavioural or sensory deficits that have reduced their previous functional capacity and quality of life. The patient is clinically stable enough to undergo rehabilitation and had a good functional situation prior to the episode (Barthel Index \> 60).
* Be over 18 years of age.
* The participant or their relatives have signed the informed consent form.
* They have completed the group music therapy intervention session, as well as the pre-test and post-test evaluations.

Exclusion Criteria

* Failure to obtain informed consent
* The Barthel Index score is below 60, indicating functional dependency.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

M. Antonia Pérez-Marín

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marián Pérez-Marín, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Valencia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Dr. Moliner

Serra, Valencia, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marián Pérez-Marín, PhD

Role: CONTACT

Phone: 0034 9639

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Miguel Fombuena, PhD

Role: primary

Selene Valero-Moreno, PhD

Role: backup

Isabel Bellver Vercher

Role: backup

Ana Alegre Soler

Role: backup

José Jorge Botella Trellis, Dr.

Role: backup

Cristina Rocío Espejo Fernández, Dra.

Role: backup

María Carmen Badía Picazo, Dra.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Meraki_Acquired Brain Injury

Identifier Type: -

Identifier Source: org_study_id